Adagene Inc. (ADAG) reporting calendar
Adagene Inc. files periodic reports with the SEC as ADAG on Nasdaq. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 1 Apr 2026
- Reports on record
- 6
Open ADAG market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 1 Apr 2026 | 91 days | 0001104659-26-038612 |
| 20-F | 31 Dec 2024 | 24 Mar 2025 | 83 days | 0001410578-25-000419 |
| 20-F | 31 Dec 2023 | 29 Mar 2024 | 89 days | 0001104659-24-041109 |
| 20-F | 31 Dec 2022 | 28 Apr 2023 | 118 days | 0001104659-23-052043 |
| 20-F | 31 Dec 2021 | 26 Apr 2022 | 116 days | 0001104659-22-050329 |
| 20-F | 31 Dec 2020 | 28 Apr 2021 | 118 days | 0001104659-21-055911 |
Source: SEC EDGAR company submissions for CIK 0001818838. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.